China Kanghui Holdings (ADR)  

(Public, NYSE:KH)   Watch this stock  
Find more results for KH
0.0000
0.0000 (0.00%)
- Close
NYSE real-time data - Disclaimer
Currency in USD
Range     -
52 week     -
Open     -
Vol. 0.00
Mkt cap     -
P/E 0.00
Div/yield     -
EPS 0.72
Shares     -
Beta     -
Inst. own     -

Key stats and ratios

Q2 (Jun '12) 2011
Net profit margin 34.28% 36.85%
Operating margin 38.30% 40.48%
EBITD margin - 46.83%
Return on average assets 10.56% 10.59%
Return on average equity 12.12% 11.79%
Employees 787 -
CDP Score - -

Address

No. 11 Changjiang North Road, Xinbei District
CHANGZHOU, JNG 213022
China
+86-519-85195556 (Phone)
+86-519-85195551 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

China Kanghui Holdings is a holding company and conducts all of its business through its two wholly owned subsidiaries in China, Changzhou Kanghui Medical Innovation Co., Ltd. (Changzhou Kanghui) and Beijing Libeier. The Company is a domestic developer, manufacturer and marketer of orthopedic implants in People’s Republic of China. The Company’s orthopedic implant brands are Kanghui and Libeier. It sells two lines of orthopedic implant products, trauma and spine. Its major trauma products, used in the surgical treatment of bone fractures, include a range of nails, plates and screws. Its major spine products, used in the surgical treatment of spine disorders, include screws, meshes, interbody cages and fixation systems. On July 31, 2008, we acquired 100% of the equity interests of Beijing Libeier. On July 31, 2009, the Company established Shanghai Zhikang Medical Devices Co., Ltd. (Shanghai Zhikang), which is wholly owned by Changzhou Kanghui.